Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. Summer 2000;10(3):96-100.
doi: 10.5737/1181912x10396100.

Testing Control of Radiation-Induced Diarrhea With a Psyllium Bulking Agent: A Pilot Study

Affiliations
Clinical Trial

Testing Control of Radiation-Induced Diarrhea With a Psyllium Bulking Agent: A Pilot Study

J Murphy et al. Can Oncol Nurs J. .

Abstract

Sixty cancer patients who were undergoing radiation therapy to the pelvis of at least 4,000 cGy in 20 fractions over four weeks were randomized to take or not take Metamucil. Results were analyzed for the presence of radiation-induced diarrhea in two groups: patients taking Metamucil (n = 30) or not taking Metamucil (n = 30). The Murphy Diarrhea Scale was developed to assist in the synthesis of data collected in daily patient-reported diaries. Results were analyzed using ANOVA F-tests. Metamucil significantly decreased the incidence (p = 0.049) and severity (p = 0.030) of diarrhea and showed a strong trend in reducing the use of anti-diarrhea medication (p = 0.062). According to this pilot study, Metamucil was an effective method of controlling radiation-induced diarrhea. Results of this pilot study have implications for clinical practice and nursing research.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

Publication types

Feedback